top of page

Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder

About the study

NCT Trial Number

NCT03434366

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Guangzhou Women and Children's Medical Center

noun_date_3237048.png

Trial Start Date

Jan-18

noun_capsule_138144.png

About the participants

Age seeking

2 Years to 15 Years   (Child)

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Autism

noun_square_138133.png

Accepts healthy volunteers?

Yes

This study will determine the efficacy and safety of intranasal ketamine with dexmedetomidine in children with Autism Spectrum Disorder..

Eyes Graffiti

Locations

China, Guangdong
Guangzhou Women and Children Medical Center
Guangzhou, Guangdong, China, 510000

Contact: Ying-Jun She, Doctor
862038076243
yjsheh@yeah.net

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page